Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021

TFFP Insider Trading (TFF Pharmaceuticals)

Insider Ownership Percentage: 9.90%
Insider Buying (Last 12 Months): $243,450.00
Insider Selling (Last 12 Months): $31,664,269.93

TFF Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at TFF Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TFF Pharmaceuticals Share Price & Price History

Current Price: $7.82
Price Change: Price Increase of +0.11 (1.43%)
As of 10/27/2021 01:00 AM ET

This chart shows the closing price history over time for TFFP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
O'Leary's Bullish on DeFi
Looking to invest into DeFi? Kevin O'Leary's stock pick could be the way to go.
Read more.

TFF Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/16/2021Glenn R. MattesCEOBuy10,000$7.10$71,000.0020,000View SEC Filing Icon  
9/16/2021Kirk Allen ColemanCFOBuy1,000$7.30$7,300.00View SEC Filing Icon  
5/19/2021Malcolm FairbairnDirectorBuy10,000$8.95$89,500.00
3/26/2021Lung Therapeutics, Inc.Major ShareholderSell715,000$14.00$10,010,000.002,235,000View SEC Filing Icon  
3/15/2021Glenn R. MattesCEOSell50,000$17.04$852,000.0060,000View SEC Filing Icon  
3/15/2021Kirk Allen ColemanCFOSell5,000$17.05$85,250.006,000View SEC Filing Icon  
3/15/2021Stephen RocamboliDirectorSell20,006$16.85$337,101.1030,478View SEC Filing Icon  
1/19/2021Robert S MillsDirectorSell55,100$19.56$1,077,756.0071,080View SEC Filing Icon  
1/15/2021Glenn R. MattesCEOSell40,000$17.51$700,400.0050,000View SEC Filing Icon  
1/15/2021Kirk Allen ColemanCFOSell5,000$17.50$87,500.006,000View SEC Filing Icon  
12/23/2020Glenn R. MattesCEOSell30,000$15.33$459,900.0040,000View SEC Filing Icon  
12/23/2020Kirk Allen ColemanCFOSell10,000$15.24$152,400.0011,000View SEC Filing Icon  
12/7/2020James Brian WindsorInsiderSell25,000$15.80$395,000.0030,000View SEC Filing Icon  
12/4/2020Lung Therapeutics, Inc.Major ShareholderSell1,050,000$13.86$14,553,000.003,500,000View SEC Filing Icon  
11/24/2020Aaron G.L. FletcherDirectorBuy5,000$15.13$75,650.00100,000View SEC Filing Icon  
11/13/2020Randy H ThurmanDirectorSell5,000$17.17$85,850.0039,504View SEC Filing Icon  
11/11/2020Malcolm FairbairnDirectorSell63,331$15.93$1,008,862.8321,278View SEC Filing Icon  
11/10/2020Glenn R. MattesCEOSell108,830$15.00$1,632,450.00118,830View SEC Filing Icon  
11/10/2020Kirk Allen ColemanCFOSell15,000$15.12$226,800.0016,000View SEC Filing Icon  
5/26/2020Aaron G.L. FletcherDirectorBuy20,000$5.08$101,600.0095,000View SEC Filing Icon  
4/15/2020Aaron G.L. FletcherDirectorBuy5,581$4.72$26,342.3275,000View SEC Filing Icon  
4/6/2020Aaron G.L. FletcherDirectorBuy6,252$4.24$26,508.4846,419View SEC Filing Icon  
4/2/2020Aaron G.L. FletcherDirectorBuy500$3.75$1,875.0046,419View SEC Filing Icon  
10/25/2019Glenn R. MattesCEOBuy10,000$5.02$50,200.00
10/25/2019Harlan F WeismanDirectorBuy5,000$5.02$25,100.00
10/25/2019Kirk Allen ColemanCFOBuy1,000$5.02$5,020.00
See Full Table
Insider Trading at TFF Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for TFF Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for TFF Pharmaceuticals (NASDAQ:TFFP)

22.36% of TFF Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TFFP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TFF Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/20/2021Mesirow Financial Investment Management Inc.40,005$0.31M0.9%+46.4%0.158%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.22,515$0.17M0.0%-45.5%0.089%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley29,209$0.28M0.0%+69.8%0.115%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC113,264$1.09M0.0%-52.7%0.447%Search for SEC Filing on Google Icon
8/17/2021Apis Capital Advisors LLC170,000$1.63M1.4%-6.8%0.670%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC25,300$0.24M0.0%+33.4%0.100%Search for SEC Filing on Google Icon
8/16/2021Nantahala Capital Management LLC367,817$3.54M0.1%-3.9%1.450%Search for SEC Filing on Google Icon
8/16/2021Occudo Quantitative Strategies LP11,901$0.11M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/16/2021First Trust Advisors LP37,350$0.36M0.0%+20.5%0.147%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley29,209$0.28M0.0%+69.8%0.115%Search for SEC Filing on Google Icon
8/16/2021State Street Corp43,878$0.42M0.0%N/A0.173%Search for SEC Filing on Google Icon
8/16/2021Carlson Capital L P215,000$2.07M0.1%+26.5%0.848%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC182,700$1.76M0.0%+182.4%0.720%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp28,042$0.27M0.0%+30.2%0.111%Search for SEC Filing on Google Icon
8/13/2021Sigma Planning Corp71,950$0.69M0.0%+6.0%0.284%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC122,302$1.18M0.0%+14.4%0.482%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.771,854$7.42M0.0%+10.8%3.043%Search for SEC Filing on Google Icon
8/12/2021Trexquant Investment LP12,226$0.12M0.0%-9.8%0.048%Search for SEC Filing on Google Icon
8/12/2021DRW Securities LLC1,000,000$9.61M0.3%+94.8%3.943%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.7,493$72K0.0%+274.3%0.030%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC26,717$0.26M0.0%N/A0.105%Search for SEC Filing on Google Icon
8/11/2021Princeton Capital Management LLC110,282$1.06M0.3%N/A0.435%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.261,514$2.51M0.0%-8.2%1.031%Search for SEC Filing on Google Icon
8/10/2021Fermata Advisors LLC20,400$0.20M0.1%+60.6%0.080%Search for SEC Filing on Google Icon
8/5/2021P.A.W. Capital Corp75,000$0.72M0.6%+17.7%0.296%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP77,283$0.74M0.1%N/A0.305%Search for SEC Filing on Google Icon
8/2/2021Venturi Wealth Management LLC8,273$80K0.0%N/A0.033%Search for SEC Filing on Google Icon
5/19/2021Diametric Capital LP32,868$0.45M0.3%N/A0.130%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC239,678$3.25M0.0%+134.5%0.945%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley17,206$0.23M0.0%+2,166.9%0.068%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC18,972$0.26M0.0%N/A0.075%Search for SEC Filing on Google Icon
5/18/2021Corriente Advisors LLC1,565,682$21.25M7.8%+16.0%6.173%Search for SEC Filing on Google Icon
5/18/2021Fermata Advisors LLC12,700$0.17M0.1%N/A0.050%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC12,209$0.17M0.0%N/A0.048%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP56,992$0.77M0.0%+186.8%0.225%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.13,947$0.19M0.0%N/A0.055%Search for SEC Filing on Google Icon
5/14/2021Nantahala Capital Management LLC382,553$5.19M0.2%-78.3%1.508%Search for SEC Filing on Google Icon
5/14/2021Gagnon Securities LLC377,976$5.13M0.8%+62.3%1.490%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp13,000$0.18M0.0%N/A0.051%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP13,547$0.18M0.0%N/A0.053%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC64,700$0.88M0.0%+84.9%0.255%Search for SEC Filing on Google Icon
5/13/2021DRW Securities LLC513,400$6.97M0.3%N/A2.024%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.17,696$0.24M0.0%-17.9%0.070%Search for SEC Filing on Google Icon
5/13/2021Carlson Capital L P170,000$2.31M0.1%N/A0.670%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC106,910$1.45M0.0%+11.8%0.422%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.2,002$27K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG5,935$81K0.0%-60.9%0.023%Search for SEC Filing on Google Icon
5/12/2021Granite Point Capital Management L.P.210,000$2.85M0.1%N/A0.828%Search for SEC Filing on Google Icon
5/10/2021P.A.W. Capital Corp63,695$0.86M0.8%N/A0.251%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.284,921$3.87M0.0%+1.8%1.123%Search for SEC Filing on Google Icon
5/7/2021University of Texas Texas AM Investment Managment Co.22,066$0.30M0.2%-90.0%0.087%Search for SEC Filing on Google Icon
5/7/2021Meridian Wealth Advisors LLC11,500$0.16M0.1%N/A0.045%Search for SEC Filing on Google Icon
5/7/2021IndexIQ Advisors LLC30,498$0.41M0.0%N/A0.120%Search for SEC Filing on Google Icon
5/6/2021Sigma Planning Corp67,900$0.92M0.0%-21.9%0.268%Search for SEC Filing on Google Icon
5/6/2021Altium Capital Management LP269,691$3.66M1.0%N/A1.063%Search for SEC Filing on Google Icon
4/27/2021Belvedere Trading LLC23,390$0.32M0.0%N/A0.101%Search for SEC Filing on Google Icon
4/27/2021Janney Montgomery Scott LLC124,408$1.69M0.0%+133.3%0.538%Search for SEC Filing on Google Icon
3/4/2021Hudson Bay Capital Management LP500,000$7.16M0.1%N/A2.250%Search for SEC Filing on Google Icon
2/16/2021Precept Management LLC150,000$2.15M0.9%-36.2%0.675%Search for SEC Filing on Google Icon
2/16/2021ExodusPoint Capital Management LP48,826$0.70M0.0%N/A0.220%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.21,564$0.31M0.0%+3,820.7%0.097%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC34,994$0.50M0.0%-67.5%0.157%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN16,317$0.23M0.0%+587.9%0.073%Search for SEC Filing on Google Icon
2/9/2021Advisory Services Network LLC7,221$0.10M0.0%+140.7%0.032%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.279,846$4.01M0.0%+10.1%1.259%Search for SEC Filing on Google Icon
2/2/2021First Trust Advisors LP28,500$0.41M0.0%-4.2%0.128%Search for SEC Filing on Google Icon
1/28/2021Venturi Wealth Management LLC8,273$0.12M0.0%N/A0.037%Search for SEC Filing on Google Icon
1/25/2021Janney Montgomery Scott LLC53,317$0.76M0.0%N/A0.240%Search for SEC Filing on Google Icon
1/14/2021Mesirow Financial Investment Management Inc.27,963$0.40M1.3%-19.9%0.126%Search for SEC Filing on Google Icon
1/12/2021Baldwin Brothers Inc. MA10,000$0.14M0.0%N/A0.045%Search for SEC Filing on Google Icon
11/17/2020Nantahala Capital Management LLC2,032,988$37.55M1.1%+137.4%9.147%Search for SEC Filing on Google Icon
11/16/2020Meridian Wealth Advisors LLC11,500$0.21M0.1%N/A0.052%Search for SEC Filing on Google Icon
11/12/2020Gagnon Securities LLC219,584$4.06M0.9%-0.3%0.988%Search for SEC Filing on Google Icon
11/12/2020Gagnon Advisors LLC176,471$3.26M2.0%N/A0.794%Search for SEC Filing on Google Icon
11/10/2020Westwood Holdings Group Inc.12,000$0.22M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/6/2020University of Texas Texas AM Investment Managment Co.220,666$4.08M4.2%N/A1.014%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.254,209$4.70M0.0%+384.3%1.168%Search for SEC Filing on Google Icon
11/5/2020California Public Employees Retirement System26,200$0.48M0.0%N/A0.120%Search for SEC Filing on Google Icon
11/5/2020First Trust Advisors LP29,746$0.55M0.0%N/A0.137%Search for SEC Filing on Google Icon
11/3/2020Corriente Advisors LLC1,058,823$19.56M9.9%N/A4.865%Search for SEC Filing on Google Icon
11/3/2020Sigma Planning Corp87,100$1.61M0.1%-7.5%0.400%Search for SEC Filing on Google Icon
10/16/2020Sanders Morris Harris LLC21,326$0.34M0.1%N/A0.098%Search for SEC Filing on Google Icon
10/13/2020Mesirow Financial Investment Management Inc.34,902$0.65M2.8%-35.7%0.160%Search for SEC Filing on Google Icon
8/14/2020Nantahala Capital Management LLC856,517$4.93M0.1%+47.9%4.587%Search for SEC Filing on Google Icon
8/13/2020Gagnon Securities LLC220,204$1.27M0.3%N/A1.179%Search for SEC Filing on Google Icon
7/31/2020Sigma Planning Corp94,150$0.54M0.0%+5.1%0.504%Search for SEC Filing on Google Icon
7/22/2020Mesirow Financial Investment Management Inc.54,264$0.31M1.5%-2.7%0.291%Search for SEC Filing on Google Icon
5/1/2020Sigma Planning Corp89,550$0.34M0.0%+752.9%0.480%Search for SEC Filing on Google Icon
5/1/2020BlackRock Inc.22,134$84K0.0%+77.8%0.119%Search for SEC Filing on Google Icon
4/9/2020Mesirow Financial Investment Management Inc.55,745$0.21M1.3%-10.8%0.299%Search for SEC Filing on Google Icon
2/14/2020Goldman Sachs Group Inc.15,880$85K0.0%N/A0.086%Search for SEC Filing on Google Icon
2/10/2020National Asset Management Inc.13,500$73K0.0%N/A0.073%Search for SEC Filing on Google Icon
2/3/2020Sigma Planning Corp10,500$56K0.0%N/A0.057%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TFF Pharmaceuticals logo
TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform in the United States and Australia. It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which has completed Phase I clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in the Phase I clinical trials used for the prevention of lung transplant rejection. It is also developing other dry powder products, such as Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various types of pain; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.
Read More on TFF Pharmaceuticals

Today's Range

Now: $7.82
Low: $7.61
High: $7.87

50 Day Range

MA: $7.91
Low: $7.01
High: $8.64

52 Week Range

Now: $7.82
Low: $6.85
High: $21.14

Volume

95,519 shs

Average Volume

139,408 shs

Market Capitalization

$198.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.18

Who are the company insiders with the largest holdings of TFF Pharmaceuticals?

TFF Pharmaceuticals' top insider shareholders include:
  1. Lung Therapeutics, Inc (Major Shareholder)
  2. Glenn R Mattes (CEO)
  3. Aaron GL Fletcher (Director)
  4. Robert S Mills (Director)
  5. Randy H Thurman (Director)
  6. Stephen Rocamboli (Director)
  7. James Brian Windsor (Insider)
  8. Malcolm Fairbairn (Director)
  9. Kirk Allen Coleman (CFO)

Who are the major institutional investors of TFF Pharmaceuticals?

TFF Pharmaceuticals' top institutional investors include:
  1. Mesirow Financial Investment Management Inc. — 0.16%
  2. Assenagon Asset Management S.A. — 0.09%

Which institutional investors are selling TFF Pharmaceuticals stock?

Within the last quarter, TFFP stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
Within the last year, company insiders that have sold TFF Pharmaceuticals company stock include:
  1. Lung Therapeutics, Inc (Major Shareholder)
  2. Glenn R Mattes (CEO)
  3. Aaron GL Fletcher (Director)
  4. Robert S Mills (Director)
  5. Randy H Thurman (Director)
  6. Stephen Rocamboli (Director)
  7. James Brian Windsor (Insider)
  8. Malcolm Fairbairn (Director)

Which institutional investors are buying TFF Pharmaceuticals stock?

In the previous quarter, TFFP stock was bought by institutional investors including:
  1. Mesirow Financial Investment Management Inc.
In the last year, these company insiders have bought TFF Pharmaceuticals stock:
  1. Lung Therapeutics, Inc (Major Shareholder)
  2. Glenn R Mattes (CEO)
  3. Aaron GL Fletcher (Director)
  4. Robert S Mills (Director)
Investors- A $3T EV space could suffer without enough copper.
But this miner may sit on tons.
See why for yourself.